These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2066 related items for PubMed ID: 19783688

  • 1. IFN-beta inhibits human Th17 cell differentiation.
    Ramgolam VS, Sha Y, Jin J, Zhang X, Markovic-Plese S.
    J Immunol; 2009 Oct 15; 183(8):5418-27. PubMed ID: 19783688
    [Abstract] [Full Text] [Related]

  • 2. IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation.
    Zhang X, Jin J, Tang Y, Speer D, Sujkowska D, Markovic-Plese S.
    J Immunol; 2009 Mar 15; 182(6):3928-36. PubMed ID: 19265172
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
    Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH.
    Immunity; 2009 Aug 21; 31(2):331-41. PubMed ID: 19682929
    [Abstract] [Full Text] [Related]

  • 4. TLR2-activated human langerhans cells promote Th17 polarization via IL-1beta, TGF-beta and IL-23.
    Aliahmadi E, Gramlich R, Grützkau A, Hitzler M, Krüger M, Baumgrass R, Schreiner M, Wittig B, Wanner R, Peiser M.
    Eur J Immunol; 2009 May 21; 39(5):1221-30. PubMed ID: 19350551
    [Abstract] [Full Text] [Related]

  • 5. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M, Ogura H, Ueda N, Tsuruoka M, Kitabayashi C, Tsuji F, Aono H, Ishihara K, Huseby E, Betz UA, Murakami M, Hirano T.
    Int Immunol; 2007 Jun 21; 19(6):695-702. PubMed ID: 17493959
    [Abstract] [Full Text] [Related]

  • 6. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
    Chen M, Chen G, Nie H, Zhang X, Niu X, Zang YC, Skinner SM, Zhang JZ, Killian JM, Hong J.
    Eur J Immunol; 2009 Sep 21; 39(9):2525-36. PubMed ID: 19670379
    [Abstract] [Full Text] [Related]

  • 7. The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells.
    Crome SQ, Wang AY, Kang CY, Levings MK.
    Eur J Immunol; 2009 Jun 21; 39(6):1480-93. PubMed ID: 19449310
    [Abstract] [Full Text] [Related]

  • 8. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
    Huber M, Heink S, Grothe H, Guralnik A, Reinhard K, Elflein K, Hünig T, Mittrücker HW, Brüstle A, Kamradt T, Lohoff M.
    Eur J Immunol; 2009 Jul 21; 39(7):1716-25. PubMed ID: 19544308
    [Abstract] [Full Text] [Related]

  • 9. Gfi1 negatively regulates T(h)17 differentiation by inhibiting RORgammat activity.
    Ichiyama K, Hashimoto M, Sekiya T, Nakagawa R, Wakabayashi Y, Sugiyama Y, Komai K, Saba I, Möröy T, Yoshimura A.
    Int Immunol; 2009 Jul 21; 21(7):881-9. PubMed ID: 19505891
    [Abstract] [Full Text] [Related]

  • 10. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL) -17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis.
    Dutzan N, Gamonal J, Silva A, Sanz M, Vernal R.
    J Clin Periodontol; 2009 May 21; 36(5):396-403. PubMed ID: 19419438
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B, Mitsdoerffer M, Kieseier BC, Chen L, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2004 Oct 21; 155(1-2):172-82. PubMed ID: 15342209
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.
    Durelli L, Conti L, Clerico M, Boselli D, Contessa G, Ripellino P, Ferrero B, Eid P, Novelli F.
    Ann Neurol; 2009 May 21; 65(5):499-509. PubMed ID: 19475668
    [Abstract] [Full Text] [Related]

  • 16. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production.
    Xie L, Li XK, Funeshima-Fuji N, Kimura H, Matsumoto Y, Isaka Y, Takahara S.
    Int Immunopharmacol; 2009 May 21; 9(5):575-81. PubMed ID: 19539560
    [Abstract] [Full Text] [Related]

  • 17. B cells as a therapeutic target for IFN-β in relapsing-remitting multiple sclerosis.
    Ramgolam VS, Sha Y, Marcus KL, Choudhary N, Troiani L, Chopra M, Markovic-Plese S.
    J Immunol; 2011 Apr 01; 186(7):4518-26. PubMed ID: 21368231
    [Abstract] [Full Text] [Related]

  • 18. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.
    Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR.
    Cell; 2006 Sep 22; 126(6):1121-33. PubMed ID: 16990136
    [Abstract] [Full Text] [Related]

  • 19. Effects of leukotriene B4 and prostaglandin E2 on the differentiation of murine Foxp3+ T regulatory cells and Th17 cells.
    Chen H, Qin J, Wei P, Zhang J, Li Q, Fu L, Li S, Ma C, Cong B.
    Prostaglandins Leukot Essent Fatty Acids; 2009 Apr 22; 80(4):195-200. PubMed ID: 19264469
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 104.